These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis. Yu XH; Zhao TQ; Wang L; Liu ZP; Zhang CM; Chen R; Li L; Liu G; Hu WC Biochem Biophys Res Commun; 2006 Mar; 341(1):82-7. PubMed ID: 16431216 [TBL] [Abstract][Full Text] [Related]
25. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency. Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495 [TBL] [Abstract][Full Text] [Related]
26. A case of severe acquired hypertriglyceridemia in a 7-year-old girl. Lilley JS; Linton MF; Kelley JC; Graham TB; Fazio S; Tavori H J Clin Lipidol; 2017; 11(6):1480-1484. PubMed ID: 28916403 [TBL] [Abstract][Full Text] [Related]
27. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076 [TBL] [Abstract][Full Text] [Related]
29. The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants. Perera SD; Wang J; McIntyre AD; Dron JS; Hegele RA J Clin Lipidol; 2023; 17(1):87-93. PubMed ID: 36476373 [TBL] [Abstract][Full Text] [Related]
30. Breaking the chains of lipoprotein lipase deficiency: A pediatric perspective on the efficacy and safety of Volanesorsen. den Hollander B; Brands MM; Nijhuis IJM; Doude van Troostwijk LJAE; van Essen P; Hofsteenge GH; Koot BG; Müller AR; Tseng LA; Stroes ESG; van de Ven PM; Wiegman A; van Karnebeek CDM Mol Genet Metab; 2024 May; 142(1):108347. PubMed ID: 38401382 [TBL] [Abstract][Full Text] [Related]
31. Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase. Excoffon KJ; Liu G; Miao L; Wilson JE; McManus BM; Semenkovich CF; Coleman T; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2532-9. PubMed ID: 9409224 [TBL] [Abstract][Full Text] [Related]
32. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347 [TBL] [Abstract][Full Text] [Related]
33. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Valdemarsson S; Hansson P; Hedner P; Nilsson-Ehle P Acta Endocrinol (Copenh); 1983 Sep; 104(1):50-6. PubMed ID: 6624364 [TBL] [Abstract][Full Text] [Related]
34. Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency. Burnett JR; Hooper AJ Curr Opin Mol Ther; 2009 Dec; 11(6):681-91. PubMed ID: 20072945 [TBL] [Abstract][Full Text] [Related]
35. Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report. Iitake C; Masuda D; Koseki M; Yamashita S Cardiovasc Diabetol; 2020 Nov; 19(1):201. PubMed ID: 33246467 [TBL] [Abstract][Full Text] [Related]
36. Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation. Kobayashi J; Tashiro J; Murano S; Morisaki N; Saito Y Clin Endocrinol (Oxf); 1998 Apr; 48(4):515-20. PubMed ID: 9640420 [TBL] [Abstract][Full Text] [Related]
37. A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia. Kobayashi J; Nagashima I; Taira K; Hikita M; Tamura K; Bujo H; Morisaki N; Saito Y Clin Chim Acta; 1999 Jul; 285(1-2):173-82. PubMed ID: 10481934 [TBL] [Abstract][Full Text] [Related]
38. Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity. Dugi KA; Dichek HL; Santamarina-Fojo S J Biol Chem; 1995 Oct; 270(43):25396-401. PubMed ID: 7592706 [TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia. Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010 [TBL] [Abstract][Full Text] [Related]
40. Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions. Kassner U; Hollstein T; Grenkowitz T; Wühle-Demuth M; Salewsky B; Demuth I; Dippel M; Steinhagen-Thiessen E Hum Gene Ther; 2018 Apr; 29(4):520-527. PubMed ID: 29641318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]